Error message

The page you requested does not exist. For your convenience, a search was performed using the query news events press coverage 2016 02 11.

Page not found

You are here

Fri, March 02, 2018

Jeffrey Kullgren was recently interviewed for the US News & World Report article, "Why You Should Talk to Your Doctor About Drug Pricing." According to Dr. Kullgren, "It's important then, especially if a patient's health changes as they age, to periodically be reviewing those medications with their health care team to ensure that they are able to get the medications that are going to be the most beneficial to them, while we avoid prescribing medications to patients who are unlikely to benefit from them and for who those unneeded prescriptions can lead to cost burdens."

The full article can be found below.

CBSSM Colloquium 2016-- call for abstracts

2016 CBSSM Research Colloquium – University of Michigan

 

Call for Abstracts

 

The Center for Bioethics and Social Sciences in Medicine (CBSSM) Research Colloquium will be held Wednesday, April 27, 2016 at the Founders Room, Alumni Center, 200 Fletcher Street, Ann Arbor, MI 48109.

The CBSSM Research Colloquium will feature the Bishop Lecture in Bioethics as the keynote address.  This year CBSSM is delighted to announce that William Dale, MD, PhD will present the Bishop Lecture with a talk entitled: "Why Do We So Often Overtreat, Undertreat, and Mistreat Older Adults with Cancer?"

William Dale, MD, PhD is Associate Professor of Medicine and Chief, Section of Geriatrics & Palliative Medicine & Director, SOCARE Clinic at the University of Chicago. A geriatrician with a doctorate in health policy and extensive experience in oncology, Dr. Dale has devoted his career to the care of older adults with cancer -- particularly prostate cancer. Dr. Dale has a special interest in the identification and treatment of vulnerable older patients who have complex medical conditions, including cancer. He is actively researching the interactions of cancer therapies with changes associated with aging.
 

 

Abstract submissions are welcome from all disciplines both within UM, as well as other institutions. CBSSM is an interdisciplinary center focusing on bioethics and social sciences in medicine. Our research program areas of interest include:

  • Clinical and Research Ethics - committed to empirical research in ethics (what some have called empirical ethics) by providing an evidence base for informed policy and practice.
  • Health Communication and Decision Making – using techniques from basic and applied research, determines the best practices for communicating health information to patients.
  • Medicine and Society - examines the way health care and bioethics are influenced by social structures and cultural ideas.
  • Health, Justice, and Community - aims to improve knowledge, understanding and practice in resource allocation and distributive justice, ethics of health policy (public and private) and community engagement, with the overarching goal of improving health equity.
  • Genomics, Health, and Society - examines the ethical, social and behavioral implications of advances in genomics.

For more information about our program areas: http://cbssm.med.umich.edu/


Submission Details: (Form is below)

  • Abstracts should contain a title, followed by the names and designations of all contributing authors and the contact details of the corresponding author.
  • Abstracts are to be a maximum of 300 words in length (exclusive of title and author information).
  • Presentations should last no more than 20 minutes, with an additional 5 minutes for questions.  The total time allotted is therefore 25 minutes per presentation. 
  • Abstracts should be submitted on the attached Abstract Submission form.  Submit abstracts via email to Kerry Ryan, kryanz@med.umich.edu. If you have questions about the abstract, please contact CBSSM at 734-615-8377 or email Kerry Ryan.
  • Deadline for abstract submission is Friday, March 11, 2016.
  • Notification:  Applicants will be notified by Friday, March 25, 2016.


Tentative Schedule for the Colloquium:


9:00-10:30 Presentations
10:45-12:00 Bishop Lecture:  William Dale, MD, PhD
12:00-1:15 Lunch
1:15-4:30 Presentations

Click here for Abstract Submission Form.

Thu, October 29, 2015

Jeremy Sussman has received much press for a recent study in JAMA about rates of treatment deintensification in diabetes. Dr. Sussman is first author of a study that found that among older diabetes patients whose treatment resulted in very low blood pressure, only a minority (27% or fewer) underwent treatment deintensification for diabetes, which represents a lost opportunity to reduce overtreatment. The study suggests practice guidelines and performance measures should place more focus on reducing overtreatment through deintensification.

Tanner Caverly and other CBSSM faculty co-authored a national survey study in JAMA examining VA primary care health-care professionals' beliefs regarding prescribing for older diabetics. This study found misperceptions about the benefits of stringent blood glucose control and concerns about negative repercussions following deintensification of therapy. This study is also being cited in a number of press articles.

Original studies:

Sussman, Jeremy B., Eve A. Kerr, Sameer D. Saini, Rob G. Holleman, Mandi L. Klamerus, Lillian C. Min, Sandeep Vijan, and Timothy P. Hofer. "Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus." JAMA Internal Medicine (2015): 1-8.

Caverly, Tanner J., Angela Fagerlin, Brian J. Zikmund-Fisher, Susan Kirsh, Jeffrey Todd Kullgren, Katherine Prenovost, and Eve A. Kerr. "Appropriate Prescribing for Patients With Diabetes at High Risk for Hypoglycemia: National Survey of Veterans Affairs Health Care Professionals." JAMA internal medicine (2015): 1-3.

Raymond De Vries and Tim Johnson served as judges in the 2018 Michigan High School Ethics Bowl. Thank you for representing CBSSM in this great event! For more information about the Michigan High School Ethics Bowl and other local ethics-related events, check out https://www.a2ethics.org/

Panel: Sexual Harassment in Medicine

Mon, November 12, 2018, 4:00pm to 5:30pm
Add to Calendar
Location: 
Biomedical Science Research Building - Kahn Auditorium

Sexual Harassment in Medicine

Welcome by Mark Schlissel, President of the University of Michigan

PANELISTS :
- Paula Johnson, President of Wellesley College, Chairperson of the National Academies committee, and member, American Academy of Arts and Sciences and the National Academy of Medicine
- Reshma Jagsi, Professor and Deputy Chair in the Department of Radiation Oncology at Michigan Medicine and Director of the Center for Bioethics and Social Sciences in Medicine, U-M

REPORT SUMMARY & MODERATION:
- Lilia Cortina,* Associate Director of ADVANCE for the College of LSA; Professor of Psychology, Women’s Studies, and Management and Organizations, U-M
- Anna Kirkland,* Director of the Institute for Research on Women and Gender; Arthur F. Thurnau Professor of Women’s Studies, U-M

In 2016, the National Academies of Sciences, Engineering, and Medicine assembled a committee to conduct a study on the impact of sexual harassment in academia on the career advancement of women in the scientific, technical, and medical workforce. The committee published a comprehensive report titled, "Sexual Harassment of Women: Climate, Culture, and Consequences in Academic Sciences, Engineering, and Medicine," in June 2018. The report identifies key findings on the causes and impacts of sexual harassment, and recommendations for institutional policies, strategies, and practices to address and prevent it.

Preventing and effectively addressing sexual harassment of women in colleges and universities has remained a challenge for decades. More than half of women faculty and staff report having been harassed. Student surveys of university systems show disturbingly similar rates, with 20–50% of women students experiencing sexually harassing behavior perpetrated by faculty or staff.

Persistent sexual harassment in STEM fields, and its adverse impacts on women’s careers, jeopardizes progress in closing the gender gap, damages research integrity, and results in a costly loss of talent. Academic sciences, engineering, and medicine share characteristics that create conditions for harassment, but many findings of the report are not limited to STEM field settings. Other fields within academia can be similarly male-dominated, hierarchical work and learning settings in which abusive cultures may form. Such environments can silence and limit the career opportunities for both the targets of the sexual harassment and bystanders, causing both men and women to leave their fields.

This panel will include a summary of the report, discussion from the report’s co-authors, commentary from disciplinary experts, and Q&A with the audience.

The panel will offer broad discussion of use to any member of the university community or the public interested in sexual harassment in academia. A reception will follow.

Sexual Harassment in the Academy Panel Discussion Series is presented by IRWG and the Office of Research, with co-sponsorship from: ADVANCE, The Office for Health Equity and Inclusion, the College of Literature Sciences, and the Arts, and the College of Engineering

Questions or for accessibility information, please contact irwg@umich.edu or (734) 764-9537.

Stephanie Kukora, MD

Faculty

Dr. Stephanie Kukora is a clinical lecturer in Neonatal-Perinatal Medicine at the University of Michigan Mott Children’s Hospital in Ann Arbor.  She completed pediatric bioethics training through the Kansas City Children’s Hospital, under the instruction of Drs.

Research Interests: 
Last Name: 
Kukora

Dean Shumway, MD

Faculty

Dean Shumway is an Assistant Professor of Radiation Oncology with the University of Michigan Health System and the Ann Arbor VA Medical Center. He received his M.D. from the University of Chicago and completed his residency training at the University of Michigan, where he served as Chief Resident. His research focuses on advancing the quality of care received by breast cancer patients, with emphasis on improving individualized care by developing interventions to enhance decision making.

Last Name: 
Shumway

Jeremy Sussman, MD, MS

Faculty

Dr. Sussman is a Research Scientist in the Center for Clinical Management Research at the Veterans Affairs Ann Arbor Health System and an Assistant Professor in the Department of Internal Medicine at the University of Michigan Medical School. He attended medical school at the University of California, San Francisco, completed internal medicine residency at Yale-New Haven Hospital, and was a Robert Wood Johnson Foundation Clinical Scholar at the University of Michigan.

Last Name: 
Sussman

Ken Langa was recently named to an Institute of Medicine committee that will examine the evidence on preventive factors and/or interventions associated with decreasing the risk of developing Alzheimer's-Type Dementia, amnestic mild cognitive impairment, and age-related cognitive impairment (i.e., primary prevention) and make recommendations to inform public health strategies and messaging and recommendations for future research.

Kathryn Moseley, MD, MPH

Pages